Type 1 regulatory T cells are associated with persistent split erythroid/lymphoid chimerism after allogeneic hematopoietic stem cell transplantation for thalassemia

Haematologica

Volumn 94, Issue 10, 2009, Pages 1415-1426

  Serafini, Giorgia ^a,b   Andreani, Marco ^a   Testi, Manuela ^a   Battarra, MariaRosa ^a   Bontadini, Andrea ^c   Biral, Eika ^d,e   Fleischhauer, Katharina ^b   Marktel, Sarah ^d   Lucarelli, Guido ^a   Roncarolo, Maria Grazia ^b,e   Bacchetta, Rosa ^b,d  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^b SAN RAFFAELE SCIENTIFIC INSTITUTE   (Italy)

^c UNIVERSITY OF BOLOGNA   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

Hematopoietic stem cell transplantation; Persistent mixed chimerism; Thalassemia; Tolerance; Type 1 regulatory T (Tr1) cells

Indexed keywords

ALLOANTIGEN; INTERLEUKIN 10;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANTIGEN SPECIFICITY; ARTICLE; CELL CLONING; CELL ISOLATION; CHILD; CHIMERA; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ERYTHROID CELL; FEMALE; HLA MATCHING; HUMAN; HUMAN CELL; LYMPHOCYTE FUNCTION; LYMPHOID CELL; MALE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRESCHOOL CHILD; REGULATORY T LYMPHOCYTE; SCHOOL CHILD; THALASSEMIA;

CHILD; CHILD, PRESCHOOL; CHIMERISM; ERYTHROID CELLS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INTERLEUKIN-10; MALE; T-LYMPHOCYTES, REGULATORY; THALASSEMIA; TRANSPLANTATION, HOMOLOGOUS;

EID: 70349642835     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2008.003129     Document Type: Article

References (52)

1. Lucarelli G, Gaziev J. Advances in the allogeneic transplantation for thalassemia. Blood Rev 2008;22:53-63.
2. Lucarelli G, Andreani M, Angelucci E. The cure of thalassemia by bone marrow transplantation. Blood Rev 2002;16:81-85 (Pubitemid 34742224)
3. Lucarelli G, Galimberti M, Polchi P, Angelucci E, Baronciani D, Giardini C, et al. Marrow transplantation in patients with thalassemia responsive to iron chelation therapy. N Engl J Med 1993;329:840-844 (Pubitemid 23267211)
4. Andreani M, Manna M, Lucarelli G, Tonucci P, Agostinelli F, Ripalti M, et al. Persistence of mixed chimerism in patients transplanted for the treatment of thalassemia. Blood 1996;87:3494-3499 (Pubitemid 26115383)
5. Andreani M, Nesci S, Lucarelli G, Tonucci P, Rapa S, Angelucci E, et al. Long-term survival of ex-thalassemic patients with persistent mixed chimerism after bone marrow transplantation. Bone Marrow Transplant 2000;25:401-404 (Pubitemid 30114034)
6. Gaziev J, Sodani P, Polchi P, Andreani M, Lucarelli G. Bone marrow transplantation in adults with thalassemia: treatment and longterm follow-up. Ann NY Acad Sci 2005;1054:196-205. (Pubitemid 43031025)
7. Bacchetta R, Bigler M, Touraine JL, Parkman R, Tovo PA, Abrams J, et al. High levels of interleukin 10 production in vivo are associated with tolerance in SCID patients transplanted with HLA mismatched hematopoietic stem cells. J Exp Med 1994;179:493-502. (Pubitemid 24058737)
8. Bacchetta R, Parkman R, McMahon M, Weinberg K, Bigler M, de Vries JE, et al. Dysfunctional cytokine production by host-reactive T-cell clones isolated from a chimeric severe combined immunodeficiency patient transplanted with haploidentical bone marrow. Blood 1995;85:1944-1953
9. Roncarolo MG, Battaglia M. Regulatory T-cell immunotherapy for tolerance to self antigens and alloantigens in humans. Nat Rev Immunol 2007;7:585-598 (Pubitemid 47123554)
10. Bach JF. Regulatory T cells under scrutiny. Nat Rev Immunol 2003;3:189-198
11. Roncarolo MG, Bacchetta R, Bordignon C, Narula S, Levings MK. Type 1 T regulatory cells. Immunol Rev 2001;182:68-79.
12. Battaglia M, Gregori S, Bacchetta R, Roncarolo MG. Tr1 cells: from discovery to their clinical application. Semin Immunol 2006;18:120-127 (Pubitemid 43248740)
13. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, et al. Foxp3+ CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006;212:8-27.
14. Sakaguchi S, Wing K, Miyara M. Regulatory T cells - a brief history and perspective. Eur J Immunol 2007;37 (Suppl 1):116-123 (Pubitemid 350131275)
15. Hoffmann P, Edinger M. CD4+CD25+ regulatory T cells and graft-versus-host disease. Semin Hematol 2006;43:62-69
16. Roncarolo MG, Gregori S, Battaglia M, Bacchetta R, Fleischhauer K, Levings MK. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 2006;212:28-50. (Pubitemid 44116698)
17. Groux H, O'Garra A, Bigler M, Rouleau M, Antonenko S, de Vries JE, et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-742 (Pubitemid 27458961)
18. Holler E, Roncarolo MG, Hintermeier-Knabe R, Eissner G, Ertl B, Schulz U, et al. Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation. Bone Marrow Transplant 2000;25:237-241 (Pubitemid 30103011)
19. Baker KS, Roncarolo MG, Peters C, Bigler M, DeFor T, Blazar BR. High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deaths. Bone Marrow Transplant 1999;23:1123-1129 (Pubitemid 29259668)
20. Weston LE, Geczy AF, Briscoe H. Production of IL-10 by alloreactive sibling donor cells and its influence on the development of acute GVHD. Bone Marrow Transplant 2006;37:207-212 (Pubitemid 43108814)
21. Battaglia M, Stabilini A, Draghici E, Migliavacca B, Gregori S, Bonifacio E, et al. Induction of tolerance in type 1 diabetes via both CD4+CD25+ T regulatory cells and T regulatory type 1 cells. Diabetes 2006;55:1571-1580 (Pubitemid 44324109)
22. VanBuskirk AM, Burlingham WJ, Jankowska-Gan E, Chin T, Kusaka S, Geissler F, et al. Human allograft acceptance is associated with immune regulation. J Clin Invest 2000;106:145-155 (Pubitemid 30437250)
23. Lucarelli G, Clift RA, Galimberti M, Angelucci E, Giardini C, Baronciani D, et al. Bone marrow transplantation in adult thalassemic patients. Blood 1999;93:1164-1167 (Pubitemid 29076130)
24. Scharf SJ, Smith AG, Hansen JA, McFarland C, Erlich HA. Quantitative determination of bone marrow transplant engraftment using fluorescent polymerase chain reaction primers for human identity markers. Blood 1995;85:1954-1963
25. Bacchetta R, Sartirana C, Levings MK, Bordignon C, Narula S, Roncarolo MG. Growth and expansion of human T regulatory type 1 cells are independent from TCR activation but require exogenous cytokines. Eur J Immunol 2002;32:2237-2245 (Pubitemid 34965886)
26. Romagnani S. Lymphokine production by human T cells in disease states. Annu Rev Immunol 1994;12:227-257 (Pubitemid 24140415)
27. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 1989;7:145-173
28. Grossman WJ, Verbsky JW, Barchet W, Colonna M, Atkinson JP, Ley TJ. Human T regulatory cells can use the perforin pathway to cause autologous target cell death. Immunity 2004;21:589-601. (Pubitemid 39370513)
29. Grossman WJ, Verbsky JW, Tollefsen BL, Kemper C, Atkinson JP, Ley TJ. Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood 2004;104:2840-2848 (Pubitemid 39434970)
30. Manilay JO, Pearson DA, Sergio JJ, Swenson KG, Sykes M. Intrathymic deletion of alloreactive T cells in prepared with a nonmyeloablative conditioning regimen. Transplantation 1998;66:96-102.
31. Khan A, Tomita Y, Sykes M. Thymic dependence of loss of tolerance in mixed allogeneic bone marrow chimeras after depletion of donor antigen. Peripheral mechanisms do not contribute to maintenance of tolerance. Transplantation 1996;62:380-387
32. Kurtz J, Wekerle T, Sykes M. Tolerance in mixed chimerism - a role for regulatory cells? Trends Immunol 2004;25:518-523
33. Dubovsky J, Daxberger H, Fritsch G, Printz D, Peters C, Matthes S, et al. Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection. Leukemia 1999;13:2059-2069
34. Kapelushnik J, Or R, Filon D, Nagler A, Cividalli G, Aker M, et al. Analysis of b-globin mutations shows stable mixed chimerism in patients with thalassemia after bone marrow transplantation. Blood 1995;86:3241-3246
35. van Leeuwen JE, van Tol MJ, Joosten AM, Wijnen JT, Khan PM, Vossen JM. Mixed T-lymphoid chimerism after allogeneic bone marrow transplantation for hematologic malignancies of children is not correlated with relapse. Blood 1993;82:1921-1928
36. Cavani A, Nasorri F, Prezzi C, Sebastiani S, Albanesi C, Girolomoni G. Human CD4+ T lymphocytes with remarkable regulatory functions on dendritic cells and nickel-specific Th1 immune responses. J Invest Dermatol 2000; 114:295-302. (Pubitemid 30417764)
37. Akdis CA, Blesken T, Akdis M, Wuthrich B, Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998;102:98-106.
38. Saidman SL. Mixed chimerism approach to induction of transplant tolerance: a review of the Massachusetts General Hospital experience. Transplant Proc 2007;39:676-677
39. Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL, et al. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med 2008;358:353-361 (Pubitemid 351159234)
40. Buhler LH, Spitzer TR, Sykes M, Sachs DH, Delmonico FL, Tolkoff-Rubin N, et al. Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation 2002;74:1405-1409
41. Balon J, Halaburda K, Bieniaszewska M, Reichert M, Bieniaszewski L, Piekarska A, et al. Early complete donor hematopoietic chimerism in peripheral blood indicates the risk of extensive graft-versus-host disease. Bone Marrow Transplant 2005;35:1083-1088 (Pubitemid 40767197)
42. Montero A, Savani BN, Kurlander R, Read EJ, Leitman SF, Childs R, et al. Lineage-specific engraftment and outcomes after T-cell-depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning. Br J Haematol 2005;130:733-739 (Pubitemid 43906645)
43. Lim ZY, Pearce L, Ho AY, Barber L, Ingram W, Usai M, et al. Delayed attainment of full donor chimaerism following alemtuzumab-based reduced-intensity conditioning haematopoeitic stem cell transplantation for acute myeloid leukaemia and myelodysplastic syndromes is associated with improved outcomes. Br J Haematol 2007;138:517-526 (Pubitemid 47063029)
44. Hill RS, Petersen FB, Storb R, Appelbaum FR, Doney K, Dahlberg S, et al. Mixed hematologic chimerism after allogeneic marrow transplantation for severe aplastic anemia is associated with a higher risk of graft rejection and a lessened incidence of acute graft-versus-host disease. Blood 1986;67:811-816 (Pubitemid 16130278)
45. Lisini D, Zecca M, Giorgiani G, Montagna D, Cristantielli R, Labirio M, et al. Donor/recipient mixed chimerism does not predict graft failure in children with b-thalassemia given an allogeneic cord blood transplant from an HLA-identical sibling. Haematologica 2008; 93:1859-1867
46. Lapierre V, Auperin A, Robinet E, Ferrand C, Oubouzar N, Tramalloni D, et al. Immune modulation and microchimerism after unmodified versus leukoreduced allogeneic red blood cell transfusion in cancer patients: results of a randomized study. Transfusion 2007;47:1691-1699 (Pubitemid 47300616)
47. Lee TH, Paglieroni T, Utter GH, Chafets D, Gosselin RC, Reed W, et al. High-level long-term white blood cell microchimerism after transfusion of leukoreduced blood components to patients resuscitated after severe traumatic injury. Transfusion 2005;45:1280-1290 (Pubitemid 41647791)
48. Lin MT, Storer B, Martin PJ, Tseng LH, Gooley T, Chen PJ, et al. Relation of an interleukin-10 promoter polymorphism to graft-versus-host disease and survival after hematopoietic-cell transplantation. N Engl J Med 2003;349:2201-2210 (Pubitemid 37485136)
49. Lin MT, Storer B, Martin PJ, Tseng LH, Grogan B, Chen PJ, et al. Genetic variation in the IL-10 pathway modulates severity of acute graft-versushost disease following hematopoietic cell transplantation: synergism between IL-10 genotype of patient and IL-10 receptor b genotype of donor. Blood 2005;106: 3995-4001. (Pubitemid 41739044)
50. La Nasa G, Littera R, Locatelli F, Lai S, Alba F, Caocci G, et al. The human leucocyte antigen-G 14-basepair polymorphism correlates with graft-versus- host disease in unrelated bone marrow transplantation for thalassaemia. Br J Haematol 2007;139:284-288 (Pubitemid 47493086)
51. Ward FJ, Hall AM, Cairns LS, Leggat AS, Urbaniak SJ, Vickers MA, et al. Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia. Blood 2008;111:680-687
52. Hall AM, Ward FJ, Vickers MA, Stott LM, Urbaniak SJ, Barker RN. Interleukin-10-mediated regulatory T-cell responses to epitopes on a human red blood cell autoantigen. Blood 2002;100:4529-4536